home / stock / alec / alec quote
Last: | $ |
---|---|
Change Percent: | 0.87% |
Open: | $30.00 |
Close: | $30.26 |
High: | $31.10 |
Low: | $29.47 |
Volume: | 421,893 |
Last Trade Date Time: | 02/12/2020 04:40:05 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $30.00 | $30.26 | $31.10 | $29.47 | 421,893 | 02-12-2020 |
$ | $28.91 | $30.00 | $32.4799 | $28.88 | 971,527 | 02-11-2020 |
$ | $35.49 | $29.26 | $35.675 | $28.05 | 1,811,252 | 02-10-2020 |
$ | $34.27 | $35.28 | $35.93 | $33.95 | 1,518,884 | 02-07-2020 |
$ | $34.19 | $34.47 | $35.00 | $33.47 | 732,350 | 02-06-2020 |
$ | $31.98 | $33.71 | $34.4299 | $30.97 | 1,133,504 | 02-05-2020 |
$ | $28.89 | $30.18 | $31.00 | $28.76 | 1,274,669 | 02-04-2020 |
$ | $27.81 | $28.19 | $28.51 | $27.59 | 611,476 | 02-03-2020 |
$ | $28.30 | $27.94 | $28.6283 | $26.67 | 639,205 | 01-31-2020 |
$ | $27.00 | $28.17 | $28.75 | $25.40 | 3,518,159 | 01-30-2020 |
$ | $25.11 | $25.94 | $26.98 | $25.08 | 696,949 | 01-29-2020 |
$ | $25.60 | $24.59 | $26.00 | $23.77 | 689,194 | 01-28-2020 |
$ | $24.77 | $25.73 | $26.07 | $24.40 | 910,505 | 01-27-2020 |
$ | $23.80 | $24.55 | $24.99 | $23.70 | 661,688 | 01-24-2020 |
$ | $25.21 | $23.275 | $25.45 | $23.24 | 988,009 | 01-23-2020 |
$ | $22.01 | $22.93 | $23.18 | $21.7122 | 409,839 | 01-22-2020 |
$ | $21.20 | $21.99 | $22.13 | $20.985 | 338,780 | 01-21-2020 |
$ | $20.06 | $21.38 | $21.84 | $19.86 | 568,371 | 01-20-2020 |
$ | $20.06 | $21.38 | $21.84 | $19.86 | 566,769 | 01-17-2020 |
$ | $19.19 | $19.89 | $20.04 | $19.0614 | 328,140 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5 th Annual Neuro Pers...
SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host a virtual event to discuss Alector Brain Carrier, a proprietary, versatile blood-brain barrier (BBB...
SOUTH SAN FRANCISCO, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a fireside chat at the Goldman Sachs 45 th Annual Global Healthcare Co...